Last reviewed · How we verify
VZW Cardiovascular Research Center Aalst — Portfolio Competitive Intelligence Brief
1 marketed
0 filed
0 Phase 3
0 Phase 2
0 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
| Drug | Generic | Phase | Class | Target | Area | First approval |
|---|---|---|---|---|---|---|
| Saline (NaCl) | Saline (NaCl) | marketed | Electrolyte solution / Crystalloid fluid | Cardiovascular / General supportive care |
Therapeutic area mix
- Cardiovascular / General supportive care · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
- Keimyung University Dongsan Medical Center · 1 shared drug class
Subscribe to ongoing alerts
Every new pipeline event for VZW Cardiovascular Research Center Aalst:
- VZW Cardiovascular Research Center Aalst pipeline updates — RSS
- VZW Cardiovascular Research Center Aalst pipeline updates — Atom
- VZW Cardiovascular Research Center Aalst pipeline updates — JSON
Cite this brief
Drug Landscape (2026). VZW Cardiovascular Research Center Aalst — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/vzw-cardiovascular-research-center-aalst. Accessed 2026-05-17.